FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileRhythm Biosciences Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RHY.AX
Rhythm Biosciences Limited Stock AnalysisComprehensive stock analysis for Rhythm Biosciences Limited (RHY.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRHY.AX
RHY.AX
Rhythm Biosciences Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RHY.AX
  1. Home
  2. Stocks
  3. Rhythm Biosciences Limited

Rhythm Biosciences Limited

🇦🇺RHY.AX•ASX

Rhythm Biosciences Limited

🇦🇺RHY.AX•ASX

Your view on RHY.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Rhythm Biosciences Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
David Atkins
Headquarters
Bio21 Institute, Parkville, VIC, AU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
David Atkins
Headquarters
Bio21 Institute, Parkville, VIC, AU
Description

Rhythm Biosciences Limited functions as a forward-thinking enterprise focused on predictive cancer diagnostics, active across both Australian and global territories. The company's core operations involve the creation, advancement, and market introduction of cutting-edge medical diagnostic technologies.

A key innovation is ColoSTAT, their specialized blood test designed for the prompt and reliable identification of colorectal cancer. Established in 2017, the firm's main offices are located in Parkville, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Rhythm Biosciences Limited. Starting points for Rhythm Biosciences Limited: EPS -AUD 0.02, beta 0.43 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Rhythm Biosciences Limited. Rhythm Biosciences Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Rhythm Biosciences Limited. Trailing twelve-month EPS for Rhythm Biosciences Limited stands at -AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Rhythm Biosciences Limited. Rhythm Biosciences Limited has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold RHY.AX12 companies
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
THOXFBioPorto A/SHealthcareOTC$73.8M
TMOThermo Fisher Scientific Inc.HealthcareNYSE$248.1B
TMO.NEThermo Fisher Scientific Inc.HealthcareNEO—
TOMDFTodos Medical Ltd.HealthcareOTC$14,081
TTOOT2 Biosystems, Inc.HealthcareOTC$11,218
TWSTTwist Bioscience CorporationHealthcareNASDAQ$7.0B
VCYTVeracyte, Inc.HealthcareNASDAQ$2.0B
VIMGFVimian Group AB (publ)HealthcareOTC$1.5B
VRCDFVerici Dx plcHealthcareOTC$4.5M
WATWaters CorporationHealthcareNYSE$43.3B
WGSGeneDx Holdings Corp.HealthcareNASDAQ$1.4B
WUXAYWuXi AppTec Co., Ltd.HealthcareOTC$45.6B
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Rhythm Biosciences Limited. Coverage tracks Rhythm Biosciences Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Rhythm Biosciences Limited.

RHY.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1